Welcome to
On Feet Nation
Prajakta Online
Sport Touch Online
Andrew Paul Online
gopalsingh2000 Online
Posted by Prajakta on September 20, 2024 at 4:33am 0 Comments 0 Likes
Posted by Sport Touch on September 20, 2024 at 4:30am 0 Comments 0 Likes
Posted by Andrew Paul on September 20, 2024 at 4:27am 0 Comments 0 Likes
Posted by Center for Neuropsychology and E on September 20, 2024 at 4:27am 0 Comments 0 Likes
In today’s fast-paced world, families often face challenges that can strain relationships and create emotional distress. Whether it’s communication issues, conflicts, or major life transitions, seeking professional support can be a vital step towards healing and growth. Family Counselling…
Emcure Pharmaceuticals Limited has filed its draft IPO (Initial Public Offering) papers with capital markets regulator SEBI. The company is looking to raise more than Rs 1,100 crore through the public issue which will include a fresh issue of equity shares upto Rs 1,100 crore and an offer for sale (OFS) of 18,168,356 equity shares by existing shareholders, including promoters of the company. Overall the issue size would be higher than Rs 1,100 crore. In terms of sales, Emcure Pharmaceuticals is the 12th largest pharmaceutical company in India. The company is engaged in developing, manufacturing and marketing a broad range of pharmaceutical products across several geographies and has a presence in 70 markets globally.
Emcure
© 2024 Created by PH the vintage. Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation